Amrutha Sridhar, MBBS, University College London Hospitals, London, UK, discusses how socioeconomic and racial inequalities persist during the enrollment process in multiple myeloma clinical trials. Patients from a lower socioeconomic background are underrepresented in clinical trials, and will have worse overall survival, even after receiving treatment. Gaps in outcomes are additionally more pronounced in older patients. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.